Seqirus Inc.

Seqirus Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of CSL Limited, Seqirus inherits emissions data and climate commitments from its parent company.

CSL Limited has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Seqirus Inc. are not detailed in the available information.

As part of its commitment to sustainability, Seqirus is aligned with the broader climate strategies of CSL Limited, which may include industry-standard practices aimed at reducing carbon emissions across Scope 1, 2, and 3 categories. The absence of specific emissions data suggests that Seqirus is in the process of developing its own climate action framework, reflecting the growing emphasis on corporate responsibility in the biopharmaceutical sector.

Overall, while Seqirus Inc. does not currently report specific emissions figures, its affiliation with CSL Limited positions it within a framework of established climate commitments and initiatives aimed at reducing environmental impact.